Celanese Corporation

CE
Sector

Materials

Industry

Chemicals

Market Cap

$7.22B

Employees

12K

Company Overview

Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it provides redispersible powders (RDP) for use in construction applications, including flooring, plasters, insulation, tiling, and waterproofing. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.

Filing Highlights

Key insights and themes extracted from this filing

10 Themes

Financial Performance

3 Insights

The company's net sales increased by $1.3 billion, or 13%, compared to the previous year, primarily due to higher volume in the Engineered Materials segment related to the M&M Acquisition and KEPCO restructuring.

Operating profit increased by $309 million, or 22%, compared to the prior year, primarily due to higher net sales in the Engineered Materials segment and a gain recognized on the formation of the Nutrinova joint venture.

Non-operating pension and other postretirement employee expense increased by $86 million compared to the same period in 2022 primarily due to higher interest costs and lower expected return on plan assets.

Growth & Strategy

3 Insights

Management Execution

3 Insights

Risk Factors

3 Insights

Competitive Position

3 Insights

Operational Efficiency

3 Insights

Innovation & Technology

3 Insights

Capital Allocation

3 Insights

ESG Initiatives

3 Insights

Market Environment

3 Insights